An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

Daisy Higginson, Evropi Theodoratou, Harish Nair, Tanvir Huda, Lina Zgaga, Suresh S Jadhav, Saad B Omer, Igor Rudan, Harry Campbell

Research output: Contribution to journalArticlepeer-review

Abstract

Measles was responsible for an estimated 100,000 deaths worldwide in 2008. Despite being a vaccine-preventable disease, measles remains a major cause of morbidity and mortality in young children. Although a safe and effective injectable measles vaccine has been available for over 50 years it has not been possible to achieve the uniformly high levels of coverage (required to achieve measles eradication) in most parts of the developing world. Aerosolised measles vaccines are now under development with the hope of challenging the delivery factors currently limiting the coverage of the existing vaccine.
Original languageEnglish
Pages (from-to)S31
JournalBMC Public Health
Volume11 Suppl 3
DOIs
Publication statusPublished - 2011

Fingerprint Dive into the research topics of 'An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children'. Together they form a unique fingerprint.

Cite this